The purpose of this study was to investigate the effect of apolipoprotein E polymorphism on lipoprotein(a) metabolism by comparing serum lipoprotein(a) concentration with apolipoprotein E genotype in a Korean male population whose high molecular weight (HMW) lipoprotein(a) frequency was 95±98%. Serum lipoprotein(a), total cholesterol, triglyceride and high-density lipoprotein-cholesterol concentrations were measured and the apolipoprotein E genotype determined in 1189 healthy Korean males. The medians of serum lipoprotein(a) concentration in the apo E 2/3 group (0.105 g/L) and the apo E 3/4 group (0´116 g/L) were signi®cantly lower than that in the apo E 3/3 group (0´155 g/L; P50´001). The medians of serum triglyceride were 1´497 mmol/L in the apo E 2/3 group, 1´356 mmol/L in the apo E 3/ 4 group, and 1´452 mmol/L in the apo E 3/3 group (P50´05). With the signi®cant difference in the serum lipoprotein(a) concentration in Korean males according to apolipoprotein E genotype, and with the negative correlation between serum triglyceride concentration and serum lipoprotein(a) concentration, it is suggested that apolipoprotein E polymorphism and serum triglyceride participate in the metabolism of lipoprotein(a) with HMW.
Apolipoprotein(a) (apo A), the unique apolipoprotein of lipoprotein(a) [Lp (a)], is a multidomain protein consisting of multiple repeats of kringle IV, one kringle V, and a protease domain. 1 Apo A is synthesized mainly in the liver 2±4 and Lp(a) is assembled by coupling the apo A and low-density lipoprotein-cholesterol (LDL-C) at the hepatocyte surface. 5 Apo A is linked by a disulphide bond with the apo B-100 of LDL-C. The molecular weight of apo A, ranging from 420 to 840 kDa according to the number of kringle IV repeats, 6 is inversely related to serum Lp(a) concentrations. 7, 8 Serum Lp(a) is genetically determined. Apo A size polymorphism accounts for 42±69% of Lp(a) concentration variations among individuals. 8, 9 Although the exact mechanism of the in vivo Lp(a) metabolism is not reported, LDL receptor gene families, such as LDL receptor and LDL receptor-related protein (LRP), are known to be related in Lp(a) metabolism. 4,10±13 Although apolipoproteinE (apo E) polymorphism affects LDL receptor and LRP metabolism, there are several con¯icting reports that apo E polymorphism affects Lp(a) metabolism. 14±18 Apo A isoforms are divided into high molecular weight (HMW) and low molecular weight (LMW) by the molecular weight of the isoforms, 19, 20 and HMW frequency in Koreans has been reported to be between 94.8 and 98%. 21±23 This makes them a good target population for investigating the effect of apo E polymorphism on Lp(a) with HMW.
With this background, the authors investigated the effect of apo E polymorphism on HMW Lp(a) metabolism by testing serum Lp(a) concentration and apo E genotype in Korean males.
MATERIALS AND METHODS
The study included 1516 Korean males who visited the health promotion centre of Samsung
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Medical Center from January 1995 to December 1997. Among the subjects, those who had diseases or conditions known to in¯uence serum Lp(a) concentration, such as acute-phase reaction, 21 renal disease, 23, 24 liver disease 25 or diabetes mellitus, 26 were excluded using the following criteria: C-reactive protein (CRP) 48 mg/L, blood urea nitrogen (BUN) 49.3 mmol/L, creatinine 4124 mmol/L, glucose 46´1 mmol/L, haemoglobin A (HbA 1c ) 48´0% or aspartate aminotransferase (AST) and alanine aminotransferase (ALT) over 40 IU/L. As 327 were excluded, 1189 adult males remained in the study. Their mean age was 50.4 years (SD 5´4).
Determination of serum lipid and other analytes
Samples were taken after a fast of at least 14 h. Measurements of BUN, creatinine, glucose, HbA1c, CRP, AST, ALT, total cholesterol, triglyceride, high-density lipoprotein-cholesterol (HDL-C) and Lp(a) were taken immediately after venepuncture. The analytical methods used were as follows: BUN, urease indophenol; creatinine, automated JaffeÂ ; glucose, hexokinase/G6PDH; AST and ALT at 378C using International Federation of Clinical Chemistry conditions; total cholesterol, triglyceride and HDL-C with an enzymatic method; and CRP by immunoturbidimetry. All were measured with a BM Hitachi 747-100 analyser (Hitachi Co, Japan). The serum concentration of LDL-C was calculated using the Friedewald formula. 27 Nineteen samples with serum triglyceride concentrations over 4´52 mmol/L were excluded from the LDL-C calculation. The calculated LDL-C concentration was corrected for Lp(a) following the recommendation of Dahlen. 28, 29 HbA 1c was measured by an ion-exchange highperformance liquid chromatography method using the Variant Hemoglobin Testing System (Bio-Rad Co, CA, USA). Lp(a) concentration was measured by rate nephelometry using the Array 360 System (Beckman Instruments, Clinical Instruments Division, CA, USA) and the Immunozyme Lp(a) kit (IMMUNO GmbH, Germany).
DNA analysis
Apo E genotype was determined by ampli®cation step using the polymerase chain reaction and the Apo E ampli®cation kit (Innogenetics NV, Belgium), with the detection step employing reverse hybridization using the INNO-LiPA Apo E kit (Innogenetics NV, Belgium).
Data analysis
One-way analysis of variance (ANOVA) was used to analyse the mean Lp(a) and triglyceride concentrations among groups according to the apo E genotype. As Lp(a) and triglyceride levels were highly skewed, we used the logarithmic transformed Lp(a) and triglyceride levels for statistical comparison. Findings were regarded as statistically signi®cant when the probability of these data under the null hypothesis was less than 0.05. Statistical calculations were performed with the SAS (Statistical Analysis System) program.
RESULTS
Of the 1189 men included in the study six had the genotype of apo Table 1 .
The serum triglyceride concentrations had negative correlation with Lp(a) concentrations (R=70´1766, P50´0001). At serum triglyceride concentrations over 2´26 mmol/L there was a more prominent negative correlation (R= 70´3280, P50´00001) (see Fig. 1 ). The median Lp(a) concentrations of the groups with apo E 2/ 3 and apo E 3/4 genotypes were 0´105 g/L (0´020±1´280) and 0´116 g/L (0´020±1´150), respectively, which showed a signi®cantly lower concentration than that of apo E 3/3 genotype of 0´155 g/L (0´020±1´120) (P50´001). However, the median Lp(a) concentration of the group with apo E 2/3 genotype showed no signi®cant difference from the group with apo E 3/4 genotype (see Table 1 ). The median values of serum triglyceride were, in descending order, apo E 2/3 genotype 1´497 mmol/L; apo E 3/4 genotype 1´452 mmol/L; and apo E 3/3 genotype 1´356 mmol/L. Subjects with apo E 2/3 and apo E 3/4 genotypes showed serum triglyceride concentrations higher than those with apo E 3/3 genotype (P50´05), but there were no signi®cant differences in serum triglyceride concentrations between apo E 2/3 and apo E 3/4 genotypes. The mean, SD, median, 25th percentile and 75th percentile of serum triglyceride and Lp(a)corrected LDL-C according to genotypes with apo E 3 allele are listed in Table 1 . The Lp(a)corrected LDL-C concentration had no signi®cant correlation with Lp(a) concentration (P40´05). The cumulative percentage of Lp(a) concentration according to the apo E genotypes was, in descending order, apo E 3/3, apo 3/4 and apo 2/3 (see Fig. 2 ). The difference in cumulative percentage of Lp(a) concentration according to apo E genotype was prominent below an Lp(a) concentration of 0´30 g/L (79´2% in apo E 3/3 genotype, 82.2% in apo E 3/4 genotype, and 84.2% in apo E 2/3 genotype).
DISCUSSION
In this study the mean of serum Lp(a) concentration with apo 3/3 genotype was 0´207 g/L and was higher than that of apo E 3/4 genotype (0´177 g/L) and apo E 2/3 genotype (0´172 g/L) by 16´9% and 20´3%, respectively.
These results are in agreement with the report of Horita et al. in a Japanese population with mean serum Lp(a) concentrations of apo E 3/3 group (0´151 g/L) and apo E 3/4 (0´137 g/L), which were higher than those of the apo E 2 group (apo E 2/3 and apo E 2/4) of 0´066 g/L. 14 In the report by Horita et al. there were gender differences in serum Lp(a) concentrations according to apo E polymorphism: males showed high values in descending order for apo E 3, apo E 4 and apo E 2 genotypes, respectively, but in females the order was apo E 4, apo E 3 and apo E 2 genotypes, respectively. 14 Our results for males correlated well with those of Horita et al.
As there were gender differences in serum Lp(a) concentration for various reasons, including sex hormones, 14, 22, 30 only males were studied.
Our results and those of Horita et al. with an oriental population showed signi®cant differences in serum Lp(a) concentration according to apo E polymorphism. 14 Studies in Caucasians showed variable results: some reported a correlation, 15, 16 whereas others reported no correlation. 17, 18 The report of de Knijff et al. revealed that the median serum concentration of Lp(a) was higher in apo E 3/4 phenotypes (0´0820 g/L) than in apo E 3/3 (0´0625 g/L) and apo E 2/3 phenotypes (0´0440 g/L), which were lower than the concentrations in our study. 15 The apo A phenotypes can be categorized into either LMW or HMW, according to the molecular weight of the isoforms. 19, 20 The LMW group includes all phenotypes with at least one of the isoforms F, B, S1 or S2, corresponding to 11±22 kringle IV repeats. The HMW group includes all phenotypes with only S3, S4 or S5 isoforms, or with null type, corresponding to 23±42 kringle IV repeats. 19, 20 The frequency of the HMW group in Koreans was 94.8±98% in our previous study, 22 which appears signi®cantly different from that of Caucasians (71´1%) as reported by Kronenberg et al. 20 The difference in frequencies in Lp(a) with HMW between Caucasians and Orientals was thought to be one of the main factors indicating that apo E polymorphism affected the serum Lp(a) concentration differently between the two races. It is very dif®cult to analyse the effect of apo E polymorphism on Lp(a) concentration in Caucasians, as Lp(a) concentration is affected by apo A phenotypes in that ethnic group. As the frequency of the HMW group is almost 100% in Koreans, it is possible to exclude the effect of the apo A phenotype and analyse solely the effect of apo E polymorphism on Lp(a) concentration.
Although the exact mechanism of Lp(a) metabolism has not yet been clari®ed, Marz et al. reported that LDL receptors and LRP participated in Lp(a) metabolism and that the LDL receptor mainly dealt with the metabolism of Lp(a) with small molecular size and LRP Lp(a) with large molecular size. 10, 11 Apo E 2-containing lipoproteins have reduced receptor-binding activities with LDL receptors and may be catabolized at a lower rate, resulting in an accumulation of triglyceride-rich lipoproteins in serum. Horita et al. postulated that the group with apo E 2 alleles showed lower serum Lp(a) concentrations than did those with the apo E 3 allele, as the LDL receptor was upregulated and the metabolism of Lp(a) increased. 14 As evidenced by Lp(a) results according to apo E genotype, the lack of correlation between serum Lp(a) concentration and serum Lp(a)-corrected LDL-cholesterol suggests that the LDL receptor does not play a major role in Lp(a) metabolism in Koreans.
As LRP metabolizes mainly Lp(a) with large molecular size, the rate of Lp(a) catabolism correlates negatively with triglyceride concentration. 31 Triglyceride concentration varies according to apo E genotype, and is higher in apo E 2 and apo E 4 genotypes than in apo E 3 genotypes. 32±34 The current study also showed that the median serum triglyceride concentration of apo E 3/3 genotypes (1´356 mmol/L) was lower than that of apo E 2/3 genotypes (1´497 mmol/L) and apo E 3/4 genotypes (1´452 mmol/L). The median serum Lp(a) concentration of apo E 3/3 genotypes was 0´155 g/L, which was higher than for apo E 2/3 genotypes (0´105 g/L) and apo E 3/4 genotypes (0´116 g/L).
Serum Lp(a) concentration is reported to have negative correlation with serum triglyceride concentration, which suggests that triglyceride plays an important role in Lp(a) metabolism. 31, 35, 36 Bartens et al. 35 reported an especially prominent negative correlation in hypertriglyceridaemic patients. In the present study there was a negative correlation between serum triglyceride concentration and serum Lp(a) concentration ( y=70´033x+24´4, R 2 =0´019, P50´0001) and was more prominent when the serum triglyceride concentration was higher than 2´26 mmol/L ( y=70´392x+26.3, R 2 =0´046, P50´0001).
In conclusion, serum Lp(a) and triglyceride concentrations in Korean males showed signi®cant differences according to apo E polymorphism. As there is a negative correlation between serum triglyceride concentration and serum Lp(a) concentration, it is suggested that apo E polymorphism and serum triglyceride participate in the metabolism of Lp(a) with HMW.
